Twitter Updates

    follow me on Twitter

    Thursday, December 29, 2011

    Cancer Incidence And Mortality Continue To Decline

    Cancer incidence and mortality continue to decline, with the most dramatic decreases in lung, prostate, and colorectal cancers among men, and breast and colorectal cancers in women, according to the latest national report card.

    "Overall cancer incidence rates for all racial/ethnic groups combined decreased by 0.7% per year during 1999-2006 for both sexes combined, by 1.3% per year during 2000-2006 for men, and by 0.5% per year during 1998-2006 for women," authors from the American Cancer Society, the CDC, the National Cancer Institute, and the North American Association of Central Cancer Registries concluded. The report, was published online in the ACS journal, Cancer.

    There has been a decline in cancer death rates since the early 1990s and that trend appears to be durable.The decreases were slightly larger for men, who had declines of 1.5% per year during 1993-2001 and 2.0% per year during 2001-2006 compared with women, whose cancer death rates declined 0.8% per year during 1994-2002 and 1.5% per year during 2002-2006," the authors wrote.

    But the news was not all good. As men saw decreased rates of prostate, lung, oral, stomach, brain, and colorectal cancers, there was a concurrent increase in the cancers of the kidney, renal, liver, and esophagus -- as well as increases in leukemia, myeloma, and melanoma of the skin.

    For women the story was similar -- decreased rates of breast, colorectal, ovarian, cervical, uterine corpus, and oral cancers, but an uptick in lung, thyroid, pancreas, bladder, and kidney cancers, as well as increases in non-Hodgkin lymphoma, melanoma, and leukemia.

    Colorectal cancer [CRC] is a focus of this year's report, not a surprising choice because the news here is good: "CRC death rates have declined since 1984 in both men and women, with an accelerated rate of decline since 2002 (for men) and 2001 (for women)."

    And a "microsimulation model" suggests that death rates from colorectal cancer could be reduced by 36% over the next decade if "1995-2000 trends for risk factor prevalence, screening, and treatment continue."But the authors point out that increased obesity among younger Americans could derail this trend.

    Please remember, as with all our articles we provide information, not medical advice. For any treatment of your own medical condition you must visit your local doctor, with or without our article[s]. These articles are not to be taken as individual medical advice.

    Deepen your understanding of "medical malpractice"... www.MedMalBook.com
    For more health info and links visit the author's web site www.hookman.com

    Thursday, December 15, 2011

    Americans living longer than ever

    Americans living longer than ever. And every year that gets tacked on to the average life expectancy costs an extra trillion dollars in expenditures by Social Security and Medicare.

    Americans are living a record 77 years and 11 months on average...according to two studies that led researchers to suggest raising the retirement age." The first study, from the CDC's National Center for Health Statistics, found that in the "US in 2007, the latest year for which figures are available," the "0.76 percent death rate is the lowest ever," driven by "a decline in deaths from heart disease and other ailments." Meanwhile, a second study published Dec. 14 in the health journal Milbank Quarterly, found that "every year that gets tacked on to the average life expectancy costs an extra trillion dollars in expenditures by Social Security and Medicare."

            Overall, the 2007 data "show continued improvements in life expectancy for all Americans, although women are faring better than men, and whites fare better than other racial groups" by a "race differential" of about "4.6 years." But, even amid this progress, vast geographical discrepancies remain -- with people in southern states still facing higher death rates than those living in other parts of the country." And, "even though Americans can expect to live longer than their parents, life expectancy in the" US "is still lower than in many other industrialized countries, including Canada and Japan. Even so, the "dramatic improvements in the health of Americans over the last 20 years" will "have unforeseen effects on the country. The Social Security and Medicare "programs weren't designed to support people for that long."

    Please remember, as with all our articles we provide information, not medical advice. For any treatment of your own medical condition you must visit your local doctor, with or without our article[s]. These articles are not to be taken as individual medical advice.

    Deepen your understanding of "medical malpractice"... www.MedMalBook.com
    For more health info and links visit the author's web site www.hookman.com

    Wednesday, November 30, 2011

    Maternal Use of Sertaline, Citalopram Linked to Septal Heart Defects in Offspring

    Women who use the antidepressants sertraline (Zoloft) or citalopram (Celexa) early in pregnancy face increased risk for septal heart defects in their offspring, BMJ reports online.

    Researchers examined data on more than 490,000 infants born in Denmark between 1996 and 2003. They found that women who filled prescriptions for sertraline and citalopram (but not other SSRIs) during their first trimester were significantly more likely to have children with septal heart defects (but not other malformations) than those who didn't use SSRIs (odds ratios: 3.2 and 2.5, respectively).
    The authors and an editorialist (both with ties to SSRI manufacturers) note that the absolute risks for septal heart defects were low: 0.9% in children exposed to at least one SSRI and 2.1% in those exposed to more than one.
    The editorialist concludes: "Clinicians and patients need to balance the small risks associated with SSRIs against those associated with undertreatment or no treatment."

    Please remember, as with all our articles we provide information, not medical advice. For any treatment of your own medical condition you must visit your local doctor, with or without our article[s]. These articles are not to be taken as individual medical advice.

    Deepen your understanding of "medical malpractice"... www.MedMalBook.com
    For more health info and links visit the author's web site www.hookman.com

    Tuesday, November 15, 2011

    Patient Balance Problems

    Millions of people may suffer from inner-ear disorders that affect their balance but not be aware that they have a problem, a new study has found.Writing in The Archives of Internal Medicine, researchers noted the connection between balance problems and falls, especially among the elderly. The findings of the study, they said, suggest that doctors should make balance tests a routine part of checkups. This is especially true in nursing and assisted-living homes, they said.

    “The big deal here really is falls,” the lead author, Dr. Yuri Agrawal of Johns Hopkins, said in an e-mail message, adding that a serious fall can be the beginning of the end for an older patient.The researchers drew on data from a federal study in which more than 5,000 people age 40 and over were surveyed about their history of falls and balance problems. They were then given examinations to determine how well they could maintain their balance in a variety of situations, including with their eyes closed.

    More than a third of the subjects, the researchers found, had the balance disorder known as vestibular dysfunction — a figure that would translate to 69 million Americans.They also found that 32 percent of the volunteers who did not report problems with dizziness showed evidence of balance problems. Though they did not experience symptoms, they were still at higher risk for falls, the study said.
    For doctors, Dr. Agrawal said, detecting balance problems in a patient is not very complicated. And treatment is available, including exercises that help people compensate for inner-ear problems that lead to poor balance.The cost of the treatment, they said, would most likely be less than medical costs associated with falls.

    Please remember, as with all our articles we provide information, not medical advice. For any treatment of your own medical condition you must visit your local doctor, with or without our article[s]. These articles are not to be taken as individual medical advice.

    Deepen your understanding of "medical malpractice"... www.MedMalBook.com
    For more health info and links visit the author's web site www.hookman.com

    Sunday, October 30, 2011

    Banned Herbal Ingredient Linked to Urinary Tract Cancer

    Natural does not equal safe, and any herb strong enough to have a potential benefit is strong enough to have potential to cause harm."
    Exposure to aristolochic acid, found in some Chinese herbal products such as Mu Tong and Fangchi, significantly increased the risk for urinary tract cancer, according to a retrospective study.Researchers in Taiwan found prescription of more than 60 grams of Mu Tong and consumption of more than 150 mg aristolochic acid were independently associated with an increased risk for urinary tract cancer.

    • Mu Tong, 61 to 100 g: OR 1.6, 95% CI 1.3 to 2.1
    • Mu Tong, >200 g: OR 2.1, 95% CI 1.3 to 3.4
    • Aristolochic acid, 151 to 250 mg: OR 1.4, 95% CI 1.1 to 1.8
    • Aristolochic acid, >500 mg: OR 2.0, 95% CI 1.4 to 2.9

    Used in Chinese herbal preparations taken for weight loss or urinary tract infections, aristolochic acid has been banned in several countries, including in Taiwan and in the U.S.The latest study found a linear, dose-dependent relationship between the amount of aristolochic acid consumed and an increased risk for urinary tract cancer (P<0.001). This was independent of arsenic exposure through drinking water, which has also been associated with bladder and urinary tract cancers.Among the more than 4,000 patients analyzed, 57% had bladder cancer and 43% had upper urinary tract cancer.
    The International Agency for Research on Cancer has classified herbal remedies containing high concentrations of aristolochic acid as carcinogenic. Traces of aristolochic acid may still be found in adulterated remedies currently on the market.
    Wang, et al "Population-based case-control study of chinese herbal products containing aristolochic acid and urinary tract cancer risk" J Nat Can Inst 2009; DOI:10.1093/jnci/djp467.

    Please remember, as with all our articles we provide information, not medical advice. For any treatment of your own medical condition you must visit your local doctor, with or without our article[s]. These articles are not to be taken as individual medical advice.

    Tuesday, October 18, 2011

    About 2 million older adults undergo abdominal surgeries in the U.S. every year, a number that's expected to grow as the proportion of older adults increases rapidly: by 2020, one in six adults is expected to be older than 65, and 15% will be over 85.
    The patient records came from the Comprehensive Hospital Abstract Reporting System, a state-wide database that contains information on the age, sex, zip code, and billed charges of patients, as well as the codes for their diagnosis and procedures.
    The study focused on complications that occurred within 90 days of discharge and deaths within 90 days of hospital admission.

    After adjusting for various factors, including hospital volume and patient characteristics, the study found that the odds of early death after abdominal surgery increased considerably for each five-year increase in age beyond 65. These associations held for patients with cancer and other diagnoses, and for both elective and nonelective procedures (P<0.001).

    The likelihood of complications increased as patients aged beyond 65 years, with the researchers finding the following associations between age and complication frequency (trend test, P<0.001):

    • 65 to 69 years, 14.6%
    • 70 to 74 years, 16.1%
    • 75 to 79 years, 18.8%
    • 80 to 84 years, 19.9%
    • 85 to 89 years, 22.6%
    • 90 and older, 22.7%

    Similarly, older patients were at higher risk of mortality. Death rates by age group were (trend test, P<0.001):

    • 65 to 69 years, 2.5%
    • 70 to 74 years, 3.8%
    • 75 to 79 years, 6.0%
    • 80 to 84 years, 8.1%
    • 85 to 89 years, 12.6%
    • 90 and older, 16.7%

    Massarweh N, et al "Impact of advancing age on abdominal surgical outcomes" Arch Surg 2009; 144: 1108-14.

    Please remember, as with all our articles we provide information, not medical advice. For any treatment of your own medical condition you must visit your local doctor, with or without our article[s]. These articles are not to be taken as individual medical advice.

    Deepen your understanding of "medical malpractice"... www.MedMalBook.com
    For more health info and links visit the author's web site www.hookman.com

    Monday, September 26, 2011

    Certain dietary supplements Selenium and Omega-3s may reduce colorectal cancer risk

    Certain dietary supplements appear to affect the development of colorectal cancer or its recurrence," according to two new studies presented during a medical conference. In one, "researchers from the US National Institute for Environmental Health Sciences found that eating a diet high in omega-3 fatty acids cut the risk of developing colorectal cancer by nearly 40 percent. In the other study, from cancer researchers in Italy, consumption of a dietary supplement containing selenium was found to reduce the chances of having polyps recur by a similar amount."

    In one study, researchers from the U.S. National Institute for Environmental Health Sciences found that eating a diet high in omega-3 fatty acids cut the risk of developing colorectal cancer by nearly 40 percent. In the other study, from cancer researchers in Italy, consumption of a dietary supplement containing selenium was found to reduce the chances of having polyps recur by a similar amount.

    In the selenium study, 411 people, 25 to 75 years old, who'd had one or more colorectal polyps removed took either a supplement or a placebo. The supplement, described as an antioxidant compound, contained 200 micrograms of selenomethionnine (a combination of selenium and methionnine), 30 milligrams of zinc, 6,000 international units of vitamin A, 180 milligrams of vitamin C and 30 milligrams of vitamin E.

    Participants had a colonoscopy one year, three years and five years after starting the regimen.

    The researchers estimated that, after 15 years, about 48 percent of those taking the supplement were free of polyps, versus about 30 percent of those not taking the supplement.

    Among the white participants, those whose diets were in the highest fourth of omega-3 fatty acid consumption were 39 percent less likely to have colorectal cancer than those in the lowest fourth. However, for reasons the authors said they did not know, no association was noted between omega-3s and a reduction of colorectal cancer risk among black participants. The disease occurs at a higher rate among blacks than whites.
    "Our finding clearly supports the evidence from previous experimental and clinical studies showing that long-chain omega-3 fatty acids inhibit tumor growth," said the study's lead author, Sangmi Kim, a postdoctoral fellow at the U.S. National Institute of Environmental Health Sciences in Research Triangle Park, N.C.

    Kim said the research supports boosting omega-3 intake through diet or perhaps by taking an omega-3 supplement. Omega-3 fatty acids are found in fish, especially oily fish such as salmon, mackerel, herring, anchovies, sardines and tuna. Plant-based sources include flax and flaxseed oil, Brussels sprouts, soybeans and soybean oil, canola oil, spinach, walnuts and kiwi.

    Please remember, as with all our articles we provide information, not medical advice. For any treatment of your own medical condition you must visit your local doctor, with or without our article[s]. These articles are not to be taken as individual medical advice.

    Deepen your understanding of "medical malpractice"... www.MedMalBook.com
    For more health info and links visit the author's web site www.hookman.com